Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene. (2019)
Attributed to:
Investigation of alpha-synuclein pathogenic mechanisms with human stem cells and neurons
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/ejn.14286
PubMed Identifier: 30472757
Publication URI: http://europepmc.org/abstract/MED/30472757
Type: Journal Article/Review
Volume: 49
Parent Publication: The European journal of neuroscience
Issue: 4
ISSN: 0953-816X